HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Onda Selected Research

Neoplasm Metastasis (Metastasis)

1/2017PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma.
1/2017The FOXO3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroaki Onda Research Topics

Disease

10Neoplasms (Cancer)
09/2021 - 03/2002
10Tuberous Sclerosis (Bourneville's Disease)
05/2007 - 03/2002
4Hamartoma
05/2007 - 03/2002
3Seizures (Absence Seizure)
05/2007 - 06/2002
2Fibrosis (Cirrhosis)
01/2024 - 01/2023
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2023 - 01/2017
2Neoplasm Metastasis (Metastasis)
01/2017 - 01/2017
2Adenocarcinoma
01/2017 - 01/2017
2Autoimmune Diseases (Autoimmune Disease)
08/2008 - 01/2005
2Epilepsy (Aura)
08/2006 - 12/2002
2Inborn Genetic Diseases (Disease, Hereditary)
12/2005 - 03/2002
2Autistic Disorder (Autism)
12/2002 - 06/2002
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2024
1Drug-Related Side Effects and Adverse Reactions
11/2022
1Inflammation (Inflammations)
11/2022
1Obesity
09/2021
1Hypoxia (Hypoxemia)
03/2011
1Vasculitis (Vasculitides)
08/2008
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2005
1Cystadenoma
10/2003
1Carcinogenesis
08/2003
1Angiomyolipoma
09/2002
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2002
1Intellectual Disability (Idiocy)
06/2002
1Astrocytoma (Pilocytic Astrocytoma)
06/2002
1Focal Cortical Dysplasia
06/2002
1Hemangioma (Angioma)
03/2002

Drug/Important Bio-Agent (IBA)

8trans-sodium crocetinate (crocetin)IBA
05/2007 - 03/2002
3Tuberous Sclerosis Complex 2 ProteinIBA
12/2005 - 09/2002
3Phosphotransferases (Kinase)IBA
08/2003 - 03/2002
2Proteins (Proteins, Gene)FDA Link
01/2017 - 08/2003
2Tuberous Sclerosis Complex 1 ProteinIBA
12/2005 - 08/2003
2Sirolimus (Rapamycin)FDA Link
03/2005 - 10/2003
1IntegrinsIBA
01/2024
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2023
1MicroRNAs (MicroRNA)IBA
01/2023
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2023
1Calcium-Binding ProteinsIBA
11/2022
1Biomarkers (Surrogate Marker)IBA
11/2022
1TeaIBA
09/2021
1PolyphenolsIBA
09/2021
1Guanosine Monophosphate (5' Guanylic Acid)IBA
09/2021
1Phosphodiesterase 3 InhibitorsIBA
01/2017
1Cyclic GMPIBA
01/2017
1Laminin ReceptorsIBA
01/2017
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2017
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2017
1Antineoplastic Agents (Antineoplastics)IBA
01/2017
1EnzymesIBA
03/2011
1Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
03/2011
1TOR Serine-Threonine KinasesIBA
03/2011
1Protein Isoforms (Isoforms)IBA
03/2011
1Pyruvate KinaseIBA
03/2011
1IsoenzymesIBA
03/2011
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2011
1DNA (Deoxyribonucleic Acid)IBA
08/2008
1Anti-Idiotypic AntibodiesIBA
08/2008
1Complementary DNA (cDNA)IBA
08/2008
1Genetic Markers (Genetic Marker)IBA
08/2008
1Chemokine ReceptorsIBA
08/2006
1Tacrolimus Binding Proteins (FKBP)IBA
08/2006
1Messenger RNA (mRNA)IBA
08/2006
1protein-tyrosine sulfotransferase (tyrosylprotein sulfotransferase)IBA
08/2006
1NF-kappa B (NF-kB)IBA
08/2006
1C-Type Lectins (C-Type Lectin)IBA
08/2006
1Interferon-gamma (Interferon, gamma)IBA
03/2005
1Inosine Triphosphate (ITP)IBA
01/2005
1Platelet-Derived Growth Factor alpha ReceptorIBA
10/2003
1Epidermal Growth Factor (EGF)IBA
10/2003
1Insulin (Novolin)FDA Link
10/2003
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2003
1MitogensIBA
08/2003
1AntibodiesIBA
08/2003
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2003
1Tyrosine (L-Tyrosine)FDA Link
09/2002
1Tyrosine Kinase InhibitorsIBA
09/2002
1Imatinib Mesylate (Gleevec)FDA Link
09/2002
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2002
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2002
1bcr-abl Fusion ProteinsIBA
09/2002

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2017 - 01/2017
2Therapeutics
03/2005 - 09/2002